2023 CVS Quality Improvement Report Highlights how teams are focussed on clinical improvement
Topics in 2023 Quality Improvement Report include:
- Engaging farm practices QI leads in two major campaigns, both to improve the use of diagnostic testing to inform treatment of respiratory disease and mastitis -
- Representing the views of nurses and support colleagues in clinical decision making -
- Strengthening of CVS' antimicrobial stewardship programme -
CVS' 2023 Quality Improvement Report, which is published today, highlights how teams around the company are driving clinical improvement.
It includes significant progress in the farm practice, where QI leads have been driving improvement in the use of diagnostic testing. This includes improving the use of nasopharyngeal swabbing in respiratory disease in calves, and improving the use of bacteria identification and antibiotic sensitivity testing in mastitis cases. These campaigns are featured in the report, which includes the key areas of clinical improvement in CVS.
The report mentions the revitalisation of the company’s antimicrobial stewardship programme, and the way ethical issues have been handled in 2023.
It also includes details of the programme to represent the views of nurses and support colleagues more clearly. The Nursing Advisory Committee, made up of 12 people from different backgrounds and talents, has been up and running since September 2023, and is evaluating new knowledge, research, treatment and equipment from nurses’ perspective.
In addition, this QI report follows the recent publication of CVS’ Clinical Governance Framework, which illustrates the essential ingredients to cultivate a culture of continuous improvement. Each improvement project outlined in this report includes the guiding elements of the clinical governance framework.
Paul Higgs, Chief Veterinary Officer, said:
Angela Rayner, Quality Improvement Director, said: